Good practice guidelines for the treatment of autistic spectrum disorders;Guía de buena práctica para el tratamiento de los trastornos del espectro autista

Revista de Neurologia

Volumn 43, Issue 7, 2006, Pages 425-438

  Fuentes Biggi, J ^a   Ferrari Arroyo, Ma José ^b,p   Boada Munoz L ^b   Tourino Aguilera E ^b   Artigas Pallares J ^c   Belinchon Carmona M ^d   Munoz Yunta J A ^e,f   Hervas Zuniga A ^g,h   Canal Bedia, R ⁱ   Hernandez J M ^d   Diez Cuervo A ^j   Idiazabal Aletxa M A ^k   Mulas, F ^l   Palacios, S ^m   Tamarit, J ⁿ   Martos Perez J ^o   Posada De La Paz, M ^b  

^a Servicio de Psiquiatría Infanto Juvenil   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DE SABADELL   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f Centro Neuropsicobiología   (Spain)

^g HOSPITAL MÚTUA DE TERRASSA   (Spain)

^h INSTITUT UNIVERSITARI DEXEUS   (Spain)

ⁱ UNIVERSITY OF SALAMANCA   (Spain)

^j JARES Y APNA FESPAU   (Spain)

^k Instituto Neurocognitivo INCIA   (Spain)

^l HOSPITAL UNIVERSITARIO LA FE   (Spain)

^m Asociación Autismo Burgos y Universidad de Burgos   (Spain)

ⁿ Departamento de Calidad de FEAPS   (Spain)

^o Centro Leo Kanner   (Spain)

^p Ministry of Science and Innovation   (Spain)

more..

Author keywords

Asperger disorder; Autism spectrum disorders; Autistic disorder; Evidence; Practice guidelines; Recommendations; Services; Support; Treatment

Indexed keywords

AUTISM; BEHAVIOR THERAPY; CLINICAL PRACTICE; COGNITIVE THERAPY; CONSENSUS DEVELOPMENT; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; FAMILY ATTITUDE; FAMILY COUNSELING; FAMILY INTERACTION; HEALTH PROGRAM; MEDICAL EXPERT; MEDLINE; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SOCIAL COMPETENCE; SUPPORT GROUP; CHILD; HUMAN;

AUTISTIC DISORDER; CHILD; HUMANS;

EID: 34249950400     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4307.2005750     Document Type: Review

References (75)

1. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943; 2: 217-50.
2. Asperger H. Die autistichen psycopathen im kindesalter. Arch Psychiatr Nervenkr 1944; 117: 76-136.
3. Baron-Cohen S. Is Asperger syndrome necessarily viewed as a disability? Focus Autism Other Dev Disabl 2002; 17: 186-91.
4. Cochrane AL. Effectiveness and efficiency. Random reflections on health services. London: London Royal Society of Medicine Press; 1999.
5. Belinchón M, Posada M, Artigas J, Canal R, Díez-Cuervo A, Ferrari MJ, et al. Guía de buena práctica en la investigación de los trastornos del espectro autista. Rev Neurol 2005; 41: 371-7.
6. TRIPdatabase. URL: http://www.tripdatabase.com. Fecha última consulta: 1.12.2005.
7. Best practices for designing and delivering effective programs for individuals with ASD. Recommendations of the collaborative Work Group on Autistic Spectrum Disorders. California: California Departments of Education and Developmental Services; 1997.
8. Clinical practice guideline: report of the recommendations. autism/ pervasive developmental disorders, assessment and intervention for young children (age 0-3 years). New York, 1999. Publication No. 4215. URL: http://www.health.state.ny.us/nysdoh/eip/autism/. Fecha última consulta: 1.12.2005.
9. Report of the MADSEC Autism Task Force. Manchester, Maine: Maine Administrators of Services for Children with Disabilities (MADSEC); 2002.
10. Evidence-based practices for children and adolescents with ASD. Review of the literature and practice guide. Children's Mental Health. Ontario, Canada; 2003.
11. Roberts JM. A review of the research to identify the most effective models of best practice in the management of children with autism spectrum disorders. Sydney: Centre for Developmental Disability Studies. Sydney University. Department of Ageing, Disability and Home Care; 2004.
12. Sinha Y, Silove N, Wheeler D, Williams K. Auditory integration training and other sound therapies for autism spectrum disorders. Cochrane Database Syst Rev 2004; 1: CD003681.
13. Best L, Milne R. Auditory integration training in autism. Southampton: Wessex Institute for Health Research and Development (WIHRD); 1997.
14. Tochel C. Sensory or auditory integration therapy for children with autistic spectrum disorders. London: Wessex Institute for Health Research and Development. University of Southampton; 2003.
15. American Academy on Pediatrics: Committee on Children with Disabilities. Auditory integration training and facilitated communication for autism. Pediatrics 1998; 102: 431-3.
16. Ayres J. Sensory integration and learning disorders. Los Angeles: Western Psychological Services; 1972.
17. De Rooy M. What is the evidence that sensory integration therapy elicits behavioural changes in children with autism (or autism spectrum disorder) compared to other/no therapy? There is insufficient evidence (level 4) to support or refute sensory integration as an intervention to increase functional play behaviours and decrease non-engaged behaviours in pre-school children with autism. Sydney: University of Western Sydney; 2004.
18. American Academy on Pediatrics: Committee on Children with Disabilities. The pediatrician' role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001; 107: e85.
19. Doughty C. What is the evidence for the effectiveness of behavioural and skill-based early intervention in young children with autism spectrum disorder (ASD)? NZHTA Technical Brief Series 2004; 3.
20. Bassett K, Green CJ, Kazanjian A. Autism and Lovaas treatment: a systematic review of effectiveness evidence. Vancouver: BC Office of Health Technology Assessment. Centre for Health Services and Policy Research. University of British Columbia (BCOHTA); 2000. p. 57.
21. Ludwig S, Harstall C. Intensive intervention programs for children with autism. Edmonton, Canada: Alberta Heritage Foundation for Medical Research (AHFMR); 2001. p. 40.
22. McGahan L. Behavioural interventions for preschool children with autism. Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. p. 88.
23. Horner RH, Carr EG, Strain PS, Todd AW, Reed HK. Problem behaviour interventions for young children with autism: a research synthesis. J Autism Dev Disord 2002; 32: 423-46.
24. National Institutes of Mental Health. Department of Health and Human Services. Mental Health: a report of the surgeon general. Rockville, MD: Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Mental Health Services; 1999.
25. Carr EG, Horner RH, Turnbull AP, Marquis JE, Magito McLaughlin D, McAtee ML, et al. Positive behavior support in people with developmental disabilities: a research synthesis. Washington DC: Monogr Am Assoc Ment Retard; 1999.
26. Ludwig-Morgensen L. There is preliminary evidence (level 4) that social stories are effective in decreasing challenging behaviours and may improve social interaction skills in children with autism spectrum disorders. Sydney: University of Western Sydney. URL: http://www.otcats.com. Fecha última consulta: 1.12.2005.
27. Schlosser RW, Lee DL. AAC: augmentative and alternative communication. York: Centre for Reviews and Dissemination, University of York; 2001.
28. American Academy of Child and Adolescent Psychiatry. Policy statement on facilitated communication. AACAP Newsletter; 1994. URL: http://www.aacap.org/ page.ww?section=Policy+Statement&name=Facilitated+Communication. Fecha última consulta: 1.12.2005.
29. American Association on Mental Retardation. AAMR board approves policy on facilitated communication. AAMR News & Notes 1994; 7: 1.
30. American Psychological Association. Resolution on facilitated communication. Los Angeles: APA; 1994.
31. White AH. Cognitive behavioural therapy in children with autistic spectrum disorder. London: Wessex Institute for Health Research and Development. University of Southampton; 2004.
32. Ball CM. Music therapy for children with autistic spectrum disorder. London: Wessex Institute for Health Research and Development. University of Southampton; 2004.
33. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol 1996; 38: 191-202.
34. Martin A, Scahill L, Klin A, Volkmar FR. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use. J Am Acad Child Adolesc Psychiatry 1999; 38: 923-31.
35. Broadstock M, Doughty C. The effectiveness of pharmacological therapies for young people and adults with autism spectrum disorder (ASD): a critical appraisal of the literature. Christchurch: New Zealand Health Technology Assessment; 2003. p. 77.
36. Barnard L, Young AH, Pearson J, Geddes J, O'Brien G. A systematic review of the use of atypical antipsychotics in autism. J Psychopharmacol 2002; 16: 93-101.
37. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002; 347: 314-21.
38. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drug Rev 2005; 19 (Suppl 1): S1-93.
39. Posey DJ, McDougle CJ. Pharmacotherapeutic management of autism. Expert Opin Pharmacother 2001; 2: 587-600.
40. Francis K. Autism interventions: a critical update. Dev Med Child Neurol 2005; 47: 493-9.
41. Canadian Autism Intervention Research Network (CAIRN). ASDs and attention deficit hyperactivity disorders: treatment with stimulants. URL: http://www.cairn-site.com/print/diag08_print.html. Fecha última consulta: 1.12.2005.
42. Di Martino A, Melis G, Cianchetti C, Zuddas A. Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study. J Child Adolesc Psychopharmacol 2004; 14: 207-18.
43. Frankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1992; 53: 77-82.
44. Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry 2005; 57: 134-8.
45. Hayashi E. Effect of melatonin on sleep-wake rhythm: the sleep diary of an autistic male. Psychiatry Clin Neurosci 2000; 54: 383-4.
46. Fuentes J, Cundin M, Gallano I, Gutiérrez JL. Pharmautisme: sistema protocolizado de tratamiento psicofarmacológico en personas con autismo y otros trastornos del desarrollo. Burgos: Confederación Autismo España; 2001.
47. Canitano R, Luchetti A, Zappella M. Epilepsy, electroencephalographic abnormalities, and regression in children with autism. J Child Neurol 2005; 20: 27-31.
48. Arroyo S, Campistol J, Comes E, Fossas P, Martínez I, Padró LL, et al. El tratamiento de las epilepsias. Guía terapéutica de la Sociedad Catalana de Neurología 2004. URL: http://scn.es/form/ guiasterap/Guiater-Epilepsia-2004.pdf. Fecha última consulta: 1.12.2005.
49. Hirtz D, Berg A, Bettis D, Camfield C, Camfield P, Crumrine P, et al. Practice parameter: treatment of the child with a first unprovoked seizure report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003; 60: 166-75.
50. Rugino TA, Samsock TC. Levetiracetam in autistic children: an openlabel study. J Dev Behav Pediatr 2002; 23: 225-30.
51. Sandler AD, Sutton KA, DeWeese J, Girardi MA, Sheppard V, Bodfish JW. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med 1999; 341: 1801-6
52. Roberts W, Weaver L, Brian J, Bryson S, Emelianova S, Griffiths AM, et al. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics 2001; 107: E71.
53. Williams KW, Wray JJ, Wheeler DM. Intravenous secretin for autism spectrum disorder. Cochrane Database Syst Rev 2005; 3: CD003495.
54. Rimland B, Callaway E, Dreyfus P. The effects of high doses of vitamin B6 on autistic children: a double-blind crossover study. Am J Psychiatry 1978; 135: 472-5.
55. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 2002; 4. CD003497.
56. 6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord 1995; 25: 481-93.
57. Kern JK, Miller VS, Cauller PL, Kendall PR, Mehta PJ, Dodd M. Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. J Child Neurol 2001; 16: 169-73.
58. Bolman WM, Richmond JA. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. J Autism Dev Disord 1999; 29: 191-4.
59. Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev 2002; 2. CD003498.
60. A systematic review and critical appraisal of the scientific evidence on craniosacral therapy. Joint Health Technology Assessment Series. Vancouver: British Columbia Office of Health Technology Assessment; 1999.
61. Levant RF. Report of the 2005 Presidential Task Force on Evidence Based Practice. Washington: American Psychological Association; 2005.
62. Hernández J, Artigas J, Martos J, Palacios S, Fuentes J, Belinchón M, et al. Guía de buena práctica para la detección temprana de los trastornos del espectro autista. Rev Neurol 2005; 41: 237-45.
63. Díez-Cuervo A, Muñoz-Yunta JA, Fuentes J, Canal R, Idiazábal MA, Ferrari MJ, et al. Guía de buena práctica para el diagnóstico de los trastornos del espectro autista. Rev Neurol 2005; 41: 299-310.
64. Dawson G, Osterling J. Early intervention in autism: effectiveness and common elements of current approaches. In Guralnick, ed. The effectiveness of early intervention: second generation research. Baltimore: Brookes; 1997. p. 307-26.
65. National Research Council. Educating children with autism. Committee on Educational Interventions for Children with Autism. In Lord C, McGee JP, eds. Division of behavioral and social sciences and education. Washington, DC: National Academy Press; 2001
66. Dawson G. Autism Summit Conference Session 3: early intervention research. Washington DC; 19-20 noviembre de 2003.
67. Smith T, Groen AD, Wynn JW. Randomized trial of intensive early intervention for children with pervasive developmental disorder. Am J Ment Retard 2000; 105: 269-85.
68. Conferencia Mundial sobre Necesidades Educativas Especiales. Acceso y calidad. Salamanca: UNESCO; 1994. URL: http://paidos.rediris.es/genysi/recursos/ doc/leyes/dec_sal.htm. Fecha última consulta: 1.12.2005.
69. EFA-Flagship 2004. The right to education for persons with disabilities: towards inclusion. URL: http://unesdoc.unesco.org/images/0013/001378/137873e. pdf. Fecha última consulta: 1.12.2005.
70. World Education Forum. Dakar, Senegal, abril 2004. Informe final. URL: http://unesdoc.unesco.org/images/0012/001211/121117s.pdf. Fecha última consulta: 1.12.2005.
71. Inclusive Education and Classroom Practices. Agencia Europea para el Desarrollo de la Educación para Necesidades Educativas Especiales, 2005 [informe]. URL: http://www.european-agency.org/iecp/downloads/summary/IECP.doc. Fecha última consulta: 1.12.2005.
72. Barthélemy C, Fuentes J, Van der Gaag R, Visconti P, Shattock P. Descripción del autismo. Asociación Internacional Autismo Europa; 2000. URL: http://iier.isciii.es/autismo/ pdf/aut_autis.pdf. Fecha última consulta: 1.12.2005.
73. Putnam RD. Bowling alone. The collapse and revival of american community. New York: Simon & Schuster; 2000.
74. The World Bank. What is social capital? PovertyNet; 1999. URL: http:// www1.worldbank.org/prem/poverty/scapital/wahtsc.htm. Fecha última consulta: 1.12.2005.
75. Gardner JF. Attainment of personal outcomes by people with developmental disabilities. Ment Retard 2005; 43: 157-74.